Extravascular T-cell recruitment requires initiation begun by Vα14+ NKT cells and B-1 B cells

Trends in Immunology

Volumn 25, Issue 8, 2004, Pages 441-449

  Askenase, Philip W ^a   Szczepanik, Marian ^b   Itakura, Atsuko ^a   Kiener, Claudia ^a   Campos, Regis A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOLIPID; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 4; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN SPECIFICITY; ASTHMA; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CANCER; COMPLEMENT ACTIVATION; CONTACT SENSITIVITY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; EXTRAVASCULAR SPACE; HUMAN; INFECTION; LIVER; MAST CELL; NATURAL KILLER CELL; NONHUMAN; PERITONEUM CELL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE ACTIVATION; THROMBOCYTE; TISSUE DISTRIBUTION;

ANIMALS; B-LYMPHOCYTES; CHEMOTAXIS, LEUKOCYTE; DERMATITIS, CONTACT; HUMANS; HYPERSENSITIVITY, DELAYED; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 3242706883     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2004.06.003     Document Type: Review

References (86)

1. Nakae S., et al. IL-1α, but not IL-1β, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity. Int. Immunol. 13:2001;1471-1478
2. Watanabe H., et al. Contact hypersensitivity: the mechanism of immune responses and T cell balance. J. Interferon Cytokine Res. 22:2002;407-412
3. Van Loveren H., et al. An early component of delayed-type hypersensitivity mediated by T cells and mast cells. J. Exp. Med. 157:1983;1604-1617
4. Trial J. Adoptive transfer of early and late delayed-type hypersensitivity reactions mediated by human T cells. Reg. Immunol. 2:1989;12-14
5. Tsuji R.F., et al. Required early complement activation in contact sensitivity with generation of C5-dependent chemotactic activity and late T cell IFN-γ: a possible initiating role of B cells. J. Exp. Med. 186:1997;1015-1026
6. Tsuji R.F., et al. Early local generation of C5a initiates the elicitation of contact sensitivity by leading to early T cell recruitment. J. Immunol. 165:2000;1588-1598
7. Tsuji R.F., et al. B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J. Exp. Med. 196:2002;1277-1290
8. Stall A.M., et al. B-1 cells: unique origins and function. Semin. Immunol. 8:1996;45-59
9. Szczepanik M., et al. B-1 B cells mediate required early T cell recruitment to elicit protein induced delayed-type hypersensitivity. J. Immunol. 171:2003;6225-6235
10. Tsuji R.F., et al. Possible involvement of C5/C5a in the efferent phase of contact sensitivity. J. Immunol. 156:1996;4444-4450
11. Askenase P.W., et al. T cell dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity. J. Exp. Med. 152:1980;1358-1374
12. d mast cell deficient mice. J. Immunol. 131:1983;2687-2694
13. Kraeuter Kops, S. et al. (1984) Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T cell-derived antigen binding factor. Lab. Invest. 50, 421-434.
14. Van Loveren H., et al. Different mechanisms of release of vasoactive amines by mast cells occur in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses. Eur. J. Immunol. 14:1984;40-47
15. Biedermann T., et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J. Exp. Med. 192:2000;1441-1451
16. Geba G.P., et al. Delayed-type hypersensitivity in mast cell deficient mice: dependence on platelets for expression of contact sensitivity. J. Immunol. 157:1996;557-565
17. Piguet P.F., et al. Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J. Exp. Med. 173:1991;673-679
18. McHale J.F., et al. Vascular endothelial cell expression of ICAM-1 and VCAm-1 at the onset of eliciting contact hypersensitivity in mice: evidence for a dominant role of TNF-α J. Immunol. 162:1999;1648-1655
19. Laudes I.J., et al. Expression and function of C5a receptor in mouse microvascular endothelial cells. J. Immunol. 169:2002;5962-5970
20. Nataf S., et al. Human T cells express the C5a receptor and are chemoattracted to C5a. J. Immunol. 162:1999;4018-4023
21. Ameisen J.C., et al. A new interpretation of the involvement of serotonin in delayed-type hypersensitivity: serotonin-2 receptor antagonists inhibit contact sensitivity by an effect on T cells. J. Immunol. 142:1989;3171-3179
22. Albert, R.H. et al. A potential role for serotonin in lymphocyte activation. J. Immunol. (in press).
23. Schoenberger S.P. BLT for speed. Nat. Immunol. 4:2003;937-939
24. Campos R.A., et al. Cutaneous immunization rapidly activates liver Vα14+invariant NKT cells to stimulate B-1 cells to initiate T cell recruitment to elicit contact sensitivity. J. Exp. Med. 198:2003;1785-1796
25. Lisbonne M., Leite-de-Moraes M.C. Invariant Vα14 NKT lymphocytes: a double-edged immuno-regulatory T cell population. Eur. Cytokine Netw. 14:2003;4
26. Taniguchi M., et al. The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21:2003;483-513
27. Stetson D.B., et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J. Exp. Med. 198:2003;1069-1076
28. Pior J., et al. Free hapten molecules are dispersed by way of the bloodstream during contact sensitization to fluorescein isothiocyanate. J. Invest. Dermatol. 113:1999;888-893
29. Wilson M., et al. The responses of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. U. S. A. 100:2003;10913-10918
30. Ptak W., et al. Initiation of delayed-type hypersensitivity by low doses of monoclonal IgE antibody. Mediation by serotonin and inhibition by histamine. J. Immunol. 146:1991;3929-3936
31. Ptak W., et al. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells. J. Immunol. 146:1991;469-475
32. +). Invest. Dermatol. 102:1994;321-327
33. 4-specific DTH-initiating cells with an unusual mixed phenotype for an antigen-specific cell. Cell. Immunol. 161:1995;244-255
34. Mukerjee S., et al. Differing role of dendritic cells and macrophages in the induction of delayed-type hypersensitivity responses to PPD. Immunology. 59:1986;229-234
35. Naito T., et al. Simultaneous activation of natural killer T cells and autoantibody production in mice injected with denatured syngeneic liver tissue. Clin. Exp. Immunol. 129:2002;397-404
36. 1 mice. Eur. J. Immunol. 32, 2551-2561.
37. Kitamura H., et al. α-Galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell. Immunol. 199:2000;37-42
38. Galli G., et al. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 197:2003;1051-1057
39. Hansen D.S., et al. CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses. Eur. J. Immunol. 33:2003;2588-2598
40. Lisbonne M., et al. Invariant Vα14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J. Immunol. 171:2003;1637-1641
41. Akbari O., et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 9:2003;582-588
42. + T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice. J. Exp. Med. 197:2003;997-1005
43. Weigmann B., et al. Diminished contact hypersensitivity response in IL-4 deficient mice at a late phase of the elicitation reaction. Scand. J. Immunol. 45:1997;308-314
44. Yokozeki H., et al. Signal transducer and activator of transcription 6 is essential in the induction of contact hypersensitivity. J. Exp. Med. 191:2000;995-1004
45. Marchal G., et al. Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte. J. Immunol. 129:1982;954-958
46. Van Loveren H., Askenase P.W. Delayed-type hypersensitivity is mediated by a sequence of two different T cell activities. J. Immunol. 133:1984;2397-2401
47. + lymphocyte homing and initiation of late phase inflammation in contact sensitivity. J. Exp. Med. 199:2004;1223-1234
48. Redegeld F., Nijkamp F.P. Immunoglobulin free light chains and mast cells: pivotal role in T cell mediated immune reactions? Trends Immunol. 24:2003;181-185
49. Paliwal V., et al. Subunits of IgM reconstitute defective contact sensitivity in B-1 cell-deficient xid mice: κ light chains recruit T cells independent of complement. J. Immunol. 169:2002;4113-4123
50. Shaw A.C., et al. Induction of Ig light chain gene rearrangement in heavy chain-deficient B cells by activated Ras. Proc. Natl. Acad. Sci. U. S. A. 96:1999;2239-2243
51. Shaw A.C. Activated Ras signals developmental progression of recombinase-activating gene (RAG)-deficient Pro-B lymphocytes. J. Exp. Med. 189:1999;123-129
52. Tamura S.-I., et al. Properties of clones of T cells that mediate delayed-type hypersensitivity against ovalbumin in mice. Cell. Immunol. 76:1983;156-170
53. Thomas W.R., et al. Hapten-specific T cell lines mediating delayed hypersensitivity to contact-sensitizing agents. J. Exp. Med. 156:1982;300-305
54. + T cell populations that mediate delayed-type hypersensitivity. J. Immunol. 133:1984;2402-2411
55. Bilenki L., et al. Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production. Eur. J. Immunol. 34:2004;345-354
56. Benoist C., Mathis D. Mast cells in autoimmune disease. Nature. 420:2002;875-878
57. Pedotti R., et al. Involvement of both 'allergic' and 'autoimmune'.mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 24:2003;479-484
58. Thomas J.W., et al. The natural autoantibody repertoire of nonobese diabetic mice is highly active. J. Immunol. 169:2002;6617-6624
59. Akashi T., et al. Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int. Immunol. 9:1997;1159-1164
60. Shlomchik M., et al. The role of B cells in 1pr/1pr-induced autoimmunity. J. Exp. Med. 180:1994;1295-1306
61. Chan O.T.M., et al. B cells are required for lupus nephritis in the polygenic Fas-intact MRL model of systemic autoimmunity. J. Immunol. 163:1999;3592-3596
62. Zheng D., et al. Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus. J. Clin. Invest. 112:2003;1211-1222
63. + B cells at the onset of autoimmune disease in (NZBxNZW)F1 mice. Eur. J. Immunol. 32:2002;2551-2561
64. Woodroff T.M., et al. A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease. J. Immunol. 171:2003;5514-5520
65. Braley-Mullin H., Yu S. Early requirement for B cells for development of spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J. Immunol. 165:2000;7262-7269
66. Tupin E., et al. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J. Exp. Med. 199:2004;417-422
67. Vivella G., Lopes-Virella M.F. Humoral immunity and atherosclerosis. Nat. Med. 9:2003;243-245
68. Vordermeier H., et al. Increase of tuberculous infection in the organs of B cell-deficient mice. Clin. Exp. Immunol. 106:1996;312-316
69. Aguirre K.M., Johnson L.L. A role for B cells in resistance to Cryptococcus neoformans in mice. Infect. Immun. 65:1997;525-530
70. Kang H., et al. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-γ, TNF-α, and inducible nitric oxide synthase. J. Immunol. 164:2000;2629-2634
71. Culkin S.J., et al. A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. J. Immunol. 158:1997;3277-3284
72. Mittrücker H.-W., et al. Cutting edge: role of B lymphocytes in protective immunity against Salmonella typhimurium infection. J. Immunol. 164:2000;1648-1652
73. Yang X., Brunham R.C. Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection. J. Immunol. 161:1998;1439-1446
74. Montagnoli C., et al. A role for antibodies in the generation of memory antifungal immunity. Eur. J. Immunol. 33:2003;1193-1204
75. Kima P.E. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J. Exp. Med. 191:2000;1063-1068
76. Hansen D.S., et al. Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. Immunity. 18:2003;391-402
77. Paciorkowski N., et al. B1 B lymphocytes play a critical role in host protection against lymphatic filarial parasites. J. Exp. Med. 191:2000;731-735
78. Balmer P., Devaney E. NK T cells are a source of early interleukin-4 following infection with third stage larvae of the filarial nematode Brugia pahangi. Infect. Immun. 70:2002;2215-2219
79. Lachmann P. Microbial subversion of the immune response. Proc. Natl. Acad. Sci. U. S. A. 99:2002;8461-8462
80. Silveira P.A., et al. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors. Eur. J. Immunol. 32:2002;3657-3666
81. Trial J. Cooperation between early acting delayed-type hypersensitivity T-cells and cultured effector cells in tumor rejection. Cancer Res. 48:1998;5922-5926
82. Van Loveren H., et al. A role for mast cells and the vasoactive amine serotonin in T cell dependent immunity to tumors. J. Immunol. 134:1985;1292-1299
83. + T cells: it may get by with a little help from its friends. J. Clin. Invest. 100:2000;1415-1417
84. Curnis F., et al. Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration. J. Clin. Invest. 110:2002;475-482
85. Regner M., Lambert P.H. Autoimmunity through infection or immunization? Nat. Immunol. 2:2001;185-188
86. Gern J.E., Busse W.W. The role of viral infections in the natural history of asthma. J. Allergy Clin. Immunol. 106:2000;201-212